by
Michael Johns, Project Manager | March 31, 2004
The chipmaker Intel and the Seattle-based research organization will construct a device, called a Raman Bioanalyzer System, that may be able, ideally, to detect chemical anomalies in individual cells and thereby be used to flag diseases in their early stages.
"The instrument beams lasers onto tiny medical samples, such as blood serum, to create images that reveal the chemical structure of molecules,"Andrew Berlin, lead researcher of Intel's Precision Biology program, said in a statement. "The goal is to determine if this technology, previously used to detect microscopic imperfections on silicon chips, can also detect subtle traces of disease."
To read more please click on the link below
Ad Statistics
Times Displayed: 19090
Times Visited: 362 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Intel chip aims to detect disease
This information is taken from an article by By Michael Kanellos, Staff Writer, CNET News.com
Submitted by Michael Johns, Staff Reporter, DOTmed.com.
